DekaBank Deutsche Girozentrale
BMY.RT

DekaBank Deutsche Girozentrale’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-188,420
Closed -$301K – 1419
2020
Q4 		$301K Sell
188,420
-110,833
-37% -$236K ﹤0.01% 1121
2020
Q3 		$604K Buy
299,253
+87,650
+41% +$250K ﹤0.01% 891
2020
Q2 		$728K Hold
211,603
– – ﹤0.01% 721
2020
Q1 		$669K Buy
+211,603
New +$697K 0.01% 698

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

DekaBank Deutsche Girozentrale's BMY.RT Position: Q1 2021 in Review

DekaBank Deutsche Girozentrale sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 188,420 shares — an estimated $301K sold.

DekaBank Deutsche Girozentrale first reported a position in BMY.RT in Q1 2020 and held it in 4 quarters. The position peaked at $728K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • DekaBank Deutsche Girozentrale reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 188,420 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $301K.
  • DekaBank Deutsche Girozentrale first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q1 2020 and held it in 4 quarters.
  • DekaBank Deutsche Girozentrale's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $728K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2021, filed 28 Apr 2021.